Nonprofit · EIN 04-3543489
SCLERODERMA CLINICAL TRIALS CONSORTIUM INC
Tax-exempt · BOSTON, MA 02118
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $326,433 | $298,602 | $27,831 | $4,030,611 | $50,000 | $3,980,611 |
| December 31, 2023 | 990 | $264,484 | $210,242 | $54,242 | $3,466,894 | $876,242 | $2,590,652 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $217,229
- Membership dues
- $7,500
- Program service revenue
- $0
- Investment income
- $109,204
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $222,300
- Salaries, compensation and benefits (total)
- $0
- Professional fundraising fees
- $0
- Legal fees
- $744
- Accounting fees
- $6,250
- Travel
- $12,936
- Program services (functional)
- $286,656
- Management and general (functional)
- $11,946
Balance sheet and other
- Total assets, start of year
- $3,466,894
- Total assets, end of year
- $4,030,611
- Total liabilities, end of year
- $50,000
- Net assets, end of year
- $3,980,611
- Net assets without donor restrictions
- $3,980,611
- Gross receipts
- $326,433
- Employees
- 0
- Year formed
- 2001
- State of legal domicile
- MA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| ROBYN THERESE DOMSIC-DEGAZIO | PRESIDENT Officer | – | $0 |
| TRACY FRENCH | VICE PRESIDE Officer | – | $0 |
| JERRY A MOLITOR | TREASURER Officer | – | $0 |
| VANESSA SMITH | SECRETARY Officer | – | $0 |
990 for the year ended December 31, 2023: 4 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| ROBYN THERESE DOMSIC-DEGAZIO | PRESIDENT Officer | 1 | $0 |
| TRACY FRENCH | VICE PRESIDE Officer | 1 | $0 |
| JERRY MOLITOR | TREASURER Officer | 1 | $0 |
| ANTONIA VALENZUELA | SECRETARY Officer | 1 | $0 |
Address and contacts
- Address (IRS master file)
- BU SCH MEDICINE 718 ALBANY ST E-5, BOSTON, MA 02118-0000
- In care of
- % TRACY FRECH
- Principal officer (990 for 2024)
- ROBYN THERESE DOMSIC-DEGAZIO
- Signed the 990
- JERRY A MOLITOR, TREASURER
- Phone
- (801) 548-4837
- Website
- WWW.SCTCONLINE.ORG
- Return prepared by
- GOLDSTEIN TAX ADVISORS
Mission
TO FOSTER SCIENTIFIC RESEARCH AND TO ADVANCE MEDICAL RESEARCH IN THE FORM OF TREATMENT TRIALS IN SCLERODERMA ON A WORLDWIDE BASIS.
Program accomplishments
- TO FOSTER SCIENTIFIC RESEARCH AND TO ADVANCE MEDICAL RESEARCH IN THE FORM OF TREATMENT TRIALS IN SCLERODERMA ON A WORLDWIDE BASIS.Expenses $286,656 · grants $222,300
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 04-3543489
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2001
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H99)
- Assets (IRS master file)
- $4,030,611
- Income (IRS master file)
- $326,433
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $326,433 | $298,602 | $4,030,611 | XML |
| 990 | December 2023 | $264,484 | $210,242 | $3,466,894 | XML |
| 990 | December 2022 | $271,981 | $177,441 | $2,536,410 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 04-3543489).
Questions about SCLERODERMA CLINICAL TRIALS CONSORTIUM INC
- What is the EIN of SCLERODERMA CLINICAL TRIALS CONSORTIUM INC?
- The employer identification number (EIN) of SCLERODERMA CLINICAL TRIALS CONSORTIUM INC is 04-3543489.
- Is SCLERODERMA CLINICAL TRIALS CONSORTIUM INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2001.
- Are donations to SCLERODERMA CLINICAL TRIALS CONSORTIUM INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does SCLERODERMA CLINICAL TRIALS CONSORTIUM INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of SCLERODERMA CLINICAL TRIALS CONSORTIUM INC due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did SCLERODERMA CLINICAL TRIALS CONSORTIUM INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of SCLERODERMA CLINICAL TRIALS CONSORTIUM INC?
- The 990 for the year ended December 31, 2024 names ROBYN THERESE DOMSIC-DEGAZIO.
- Who are the officers and directors of SCLERODERMA CLINICAL TRIALS CONSORTIUM INC?
- The 990 for the year ended December 31, 2024 lists 4 people; 0 received compensation from the organization.
- How much revenue does SCLERODERMA CLINICAL TRIALS CONSORTIUM INC have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $326,433, expenses of $298,602 and total assets of $4,030,611 at year end.
Other nonprofits in BOSTON
- DANA-FARBER CANCER INSTITUTE EIN 04-2263040 · last filed 990 for 2025
- DANA FARBER MASS GENERAL BRIGHAM CANCER CARE INC EIN 04-3320640 · last filed 990 for 2025
- BAIM INSTITUTE FOR CLINICAL RESEARCH INC EIN 04-3521077 · last filed 990 for 2025
- BOSTON VA RESEARCH INSTITUTE INC EIN 04-3081524 · last filed 990 for 2025
- CENTER FOR INFORMATION AND STUDY ON CLINICAL RESEARCH PARTICIPATION EIN 20-0588190 · last filed 990 for 2025
- HEALTH EFFECTS INSTITUTE EIN 04-2708045 · last filed 990 for 2025
- INSTITUTE FOR PROTEIN INNOVATION INC EIN 81-3250208 · last filed 990 for 2025
- DIGITAL MEDICINE SOCIETY INC EIN 83-4205470 · last filed 990 for 2024